Figure 1.
Changes from the baseline systolic BP following treatment at weeks 4, 8 and 12 and the following treatment at post-week 4 in (A) the placebo group (n=17) and GH group (n=15) of prehypertensive subjects and in (B) the placebo group (n=21) and GH group (n=19) of mildly hypertensive subjects. *P<0.05, **P<0.01 against placebo value. White bars represent the placebo groups, and black bars represent GH groups. GH, garlic homogenate-based supplementary diet; BP, blood pressure.